Scholars@Duke publication: Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation.

Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation.

Publication , Journal Article

Chae, YS; Choi, JS; Lee, JH; Kim, KS; Lee, WJ; Kim, BR

Published in: Korean Journal of Hepatobiliary Pancreatic Surgery

January 9, 2001

Korean Journal of Hepatobiliary Pancreatic Surgery

January 9, 2001

169 / 173

Korea

APA

Chicago

ICMJE

MLA

NLM

Chae, Y. S., Choi, J. S., Lee, J. H., Kim, K. S., Lee, W. J., & Kim, B. R. (2001). Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation. Korean Journal of Hepatobiliary Pancreatic Surgery, 5(1), 169–173.

Chae, Y. S., J. S. Choi, J. H. Lee, K. S. Kim, W. J. Lee, and B. R. Kim. “Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation.” Korean Journal of Hepatobiliary Pancreatic Surgery 5, no. 1 (January 9, 2001): 169–73.

Chae YS, Choi JS, Lee JH, Kim KS, Lee WJ, Kim BR. Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation. Korean Journal of Hepatobiliary Pancreatic Surgery. 2001 Jan 9;5(1):169–73.

Chae, Y. S., et al. “Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation.” Korean Journal of Hepatobiliary Pancreatic Surgery, vol. 5, no. 1, Jan. 2001, pp. 169–73.